Depomed News
Most Popular Depomed Story
Depomed readies another Phase III for Serada
Depomed is hoping that the third time proves to be the charm for Serada, its experimental drug for hot flashes. Last October the developer's stock price was pounded after it unveiled data from two Read more...
Latest Headlines
- December 19, 2011
- August 6, 2010
- January 19, 2010
- October 12, 2009
- September 19, 2007
- September 17, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
